Navigation Links
Bcureful® Aids in the Development of New Tuberous Sclerosis Complex Center at Ann & Robert H. Lurie Children’s Hospital of Chicago

Chicago, IL (PRWEB) October 02, 2013

Bcureful®—a non-profit organization whose mission is to accelerate research towards a cure for Tuberous Sclerosis Complex (TSC)—presented its inaugural donation in the amount of $20,000.00 to launch the new Tuberous Sclerosis Complex Center at Ann & Robert H. Lurie Children’s Hospital of Chicago.

Lurie Children’s is considered one of the top children’s hospitals in the country and is a recognized leader in pediatric patient care, research, education and advocacy. Bcureful Founder and Chair Julie Scroggins and Bcureful Board member Lori Nerheim presented the check to Dr. Douglas R. Nordli, Jr. who heads the Epilepsy Center of Excellence and Dr. Srishti Nangia who will lead the new TSC Center.

This exciting project, under the direction of Dr. Nordli and his colleague Dr. Nangia, will establish a high-quality, multi-disciplinary clinic that will improve access and quality of care for TSC patients and their families throughout the Midwest. They have an outstanding team across all the various subspecialties already assembled and plan to have the program piloted by the end of the year.

Dr. Nangia explained, “Tuberous Sclerosis Complex (TSC) is a genetic disorder that involves multiple organ systems and potentially can cause serious medical issues. Fortunately, new diagnostic techniques and therapeutic advances bring the promise of improved outcomes. We have an excellent team of experts in multiple subspecialties at Ann & Robert H. Lurie Children’s Hospital of Chicago but up to now our families have faced the challenge of juggling multiple physician visits per year while sometimes traveling long distances to receive their care. The multidisciplinary TSC clinic will allow us to provide comprehensive care in a much more efficient manner and will pave the way for new clinical trials.”

Bcureful Founder Julie Scroggins added, “We are extremely honored to present these inaugural funds to Lurie Children’s to establish their new TSC Center and are committed to raising the additional $30,000.00 needed. Please support Bcureful’s goal to make this center a reality and improve the lives of so many affected by TSC.”

“In this increasingly cost conscious health care environment we believe organizations like Bcureful can uniquely provide critical support to develop novel clinical programs and launch new research initiatives,” said Dr. Nordli. “These effective partnerships will be increasingly important in the years to come and we are very excited to be participating in this ground breaking effort. For all of these reasons, we are absolutely thrilled and honored to receive this donation. We are eager to work collaboratively with Bcureful in building a state-of-the-art TSC program.”

Bcureful is a 501(c)(3) non-profit organization founded to focus resources on Tuberous Sclerosis Complex, or TSC. TSC is a genetic disorder that affects 1 in 6,000 newborns causing non- malignant tumors to develop in the brain and other vital organs. Although the growths are almost always benign, they can cause devastating effects on multiple aspects of development. It is estimated that 1 to 2 million people worldwide have TSC. Research for TSC has led to breakthroughs in autism, epilepsy and cancer.

To learn more about Bcureful and make a donation, visit


Bcureful® Board member Lori Nerheim, Founder Julie Scroggins and volunteer Cindy Raymond present Bcureful’s inaugural donation to Dr. Srishti Nangia and Dr. Douglas R. Nordli, Jr. of Ann & Robert H. Lurie Children’s Hospital of Chicago, to aid in the development of their new Tuberous Sclerosis Complex Center.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bcureful® Helps Fund Promising Tuberous Sclerosis Complex Research Project at NYU Langone Medical Center
2. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
3. Kudos for 3 NJIT Enterprise Development Center high-tech companies
4. 2 repressor genes identified as essential for placental development
5. Louisiana Tech University professor earns NSF Early Career Development grant
6. Advanced genetic screening method may speed vaccine development
7. New biospecimens management system in development
8. Developmental Woes Common in Siblings of Children With Autism
9. Mutations impair childhood growth and development by disrupting organization of chromosome pairs
10. Penn and Cornell researchers spearhead the development of new guidelines for veterinary CPR
11. Study sheds new light on role of genetic mutations in colon cancer development
Post Your Comments:
(Date:11/26/2015)... Karnataka (PRWEB) , ... November ... ... innovative online platform for mental health and wellness consultation, has collaborated with ... to holistically address their reader’s queries on topics on mental and emotional ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a global ... attracts volunteers together who want to combine talents and resources to help create ... the process. The non-profit launched its first major fundraiser on November 6, 2015 ...
(Date:11/25/2015)... Omaha, Neb. (PRWEB) , ... November 25, 2015 ... ... nurse staffing companies, has been recognized once again for its stellar workplace culture ... Places to Work.” , Medical Solutions’ Cincinnati office was named a ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior ... (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, civil societies ... the opening of the 5th African Network for Drugs and Diagnostics Innovation, ANDI, ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published ... and more widely heralded as a breakthrough for performing hernia repairs. The article explains ... laparoscopic surgery is that it can greatly reduce the pain that a patient might ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... of self-monitoring blood glucose devices was valued at $11,171.1 ... with a CAGR of 5.7% during 2015 - 2022. ... population and increasing prevalence of diabetes. In addition, the ... care is also contributing to the growth of the ...
(Date:11/25/2015)... , November 25, 2015 Developmental, commercial, ... role in boosting the profitability of pharmaceutical products, ... commercial, and regulatory/legal strategies all play a ... says GBI Research . --> ... play a key role in boosting the profitability of pharmaceutical products, ...
(Date:11/25/2015)... 25, 2015 --> ... eine Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, ... ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... Leben gerufenen und von Edelris gemeinsam mit seinen Partnern ... Behandlungsziel für HBV identifiziert, und es wurden neue Inhaltsstoffe ...
Breaking Medicine Technology: